HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiangiogenic effects of cucurbitacin-I.

Abstract
Cucurbitacin-I is a naturally occurring tetracyclic triterpenoid compound with diverse physiological actions that include inducing apoptosis and blocking cell cycle progression of various cancer cells. However, its antiangiogenic activity has not yet been examined. Accordingly, we investigated the antiangiogenic efficacy and associated mechanisms of cucurbitacin-I in vitro using human umbilical vein endothelial cells (HUVECs). Cucurbitacin-I inhibited HUVEC proliferation, invasion, migration and tubule formation, as well as angiogenic activity by rat aorta explants. Notably, cucurbitacin-I inhibited phosphorylation of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1, which are key regulators of endothelial cell function and angiogenesis. In vivo matrigel plug assay in mice showed significant decrease in vascularization and hemoglobin content in the plugs from cucurbitacin-I-treated mice, compared with control mice. Overall, these results suggest that cucurbitacin-I inhibits various attributes of angiogenesis, which might contribute to its reported antitumor effects. Cucurbitacin-I warrants further investigation as an angiogenesis inhibitor for use in cancer treatment.
AuthorsHyeon Jin Kim, Jin-Kyung Kim
JournalArchives of pharmacal research (Arch Pharm Res) Vol. 38 Issue 2 Pg. 290-8 (Feb 2015) ISSN: 1976-3786 [Electronic] Korea (South)
PMID24733676 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inhibitors
  • Triterpenes
  • Receptor, Fibroblast Growth Factor, Type 1
  • Vascular Endothelial Growth Factor Receptor-2
  • cucurbitacin I
Topics
  • Angiogenesis Inhibitors (pharmacology)
  • Animals
  • Aorta (drug effects)
  • Cell Culture Techniques
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Endothelial Cells (drug effects, pathology)
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microvessels (drug effects, growth & development)
  • Molecular Structure
  • Phosphorylation
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Fibroblast Growth Factor, Type 1 (antagonists & inhibitors)
  • Triterpenes (pharmacology)
  • Vascular Endothelial Growth Factor Receptor-2 (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: